These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 2832130)

  • 1. Mammary tumor and melanoma cell transport of PTT.119, a bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Bekesi JG
    Chemotherapy; 1988; 34(1):61-70. PubMed ID: 2832130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
    Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.
    Yagi MJ; Zanjani M; Holland JF; Bekesi JG
    Cancer Chemother Pharmacol; 1984; 12(2):77-82. PubMed ID: 6697428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cancericidal activity of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. I. In vitro cytotoxicity.
    Yagi MJ; Bekesi JG; Daniel MD; Holland JF; De Barbieri A
    Cancer Chemother Pharmacol; 1984; 12(2):70-6. PubMed ID: 6421500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
    Yagi MJ; Chin SE; Scanlon KJ; Holland JF; Bekesi JG
    Biochem Pharmacol; 1985 Jul; 34(13):2347-54. PubMed ID: 4040366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of mouse mammary tumor virus replication by PTT.119 [p-fluoro-L-phe-m-bis-(2-chloroethyl)amino-L-phe-met ethoxy HCl]--an antitumor agent.
    Yagi MJ; Maldarelli F; Chin SE; Holland JF; Bekesi JG
    J Natl Cancer Inst; 1986 Mar; 76(3):493-501. PubMed ID: 3005743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119.
    Roboz J; Greaves J; Yagi MJ; Holland JF; Bekesi JG
    Pharmacology; 1985; 30(1):52-9. PubMed ID: 3975256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.
    Yagi MJ; Bekesi JG
    Cancer Chemother Pharmacol; 1990; 26(3):215-20. PubMed ID: 2357770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 3-(p-fluorophenyl)-L-alanyl-3-[m-bis-(2-chloroethyl) aminophenyl]-L-alanyl-L-methionine ethyl ester HCl (PTT.119) against xenografts of human rhabdomyosarcoma.
    Houghton PJ; Tharp R; Houghton JA; Holland JF; Bekesi JG
    Cancer Chemother Pharmacol; 1988; 22(3):201-4. PubMed ID: 3409455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopharmacological studies of PTT.119, a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative.
    Allegrucci M; Ballerini P; Romani L; Frati L
    Immunopharmacol Immunotoxicol; 1987; 9(1):71-86. PubMed ID: 3450712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).
    Verlicchi F; Boschi S; Visani G; Guidi A; Tosi P; Cavo M; Tura S
    Blut; 1990 Nov; 61(5):311-3. PubMed ID: 2271778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxyacetate (NSC 294859) on experimental animal tumor and leukemia systems.
    Catsoulacos P
    Oncology; 1983; 40(4):290-2. PubMed ID: 6866424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of estrogen to alter amino acid transport in R3230AC mammary carcinomas and its relationship to insulin action.
    Hissin PJ; Hilf R
    Cancer Res; 1979 Sep; 39(9):3381-7. PubMed ID: 157804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstane-17-oic-13,17-lactam(p-(bis(2-chloroethyl)amino)-phenyl) acetate(NSC 290205) in murine solid tumors.
    Catsoulacos P; Wampler GL
    Oncology; 1982; 39(2):109-112. PubMed ID: 7063163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by analogues of L-tyrosine transport by B16/F10 melanoma cells.
    Jara JR; Martinez-Liarte JH; Solano F
    Melanoma Res; 1991; 1(1):15-21. PubMed ID: 1822766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging.
    Way JD; Wang M; Hamann I; Wuest M; Wuest F
    Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzymatically cleavable specific transport forms of cancerostatics. 3. 4-/N.N-bis-(2-chlorethyl)-amino/-derivatives of phenyl-O-beta-D-cellobiosids and pyrocatechol-bis-/O-beta-D-cellobiosids].
    Schwabe K; Graffi A; Redslob J; Hülsmann W; Butschak G
    Pharmazie; 1976 Jul; 31(7):438-41. PubMed ID: 981295
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake of 3-[125I]iodo-alpha-methyl-L-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs.
    Shikano N; Ogura M; Okudaira H; Nakajima S; Kotani T; Kobayashi M; Nakazawa S; Baba T; Yamaguchi N; Kubota N; Iwamura Y; Kawai K
    Nucl Med Biol; 2010 Feb; 37(2):197-204. PubMed ID: 20152719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
    Vistica DT; Ahmad S; Fuller R; Hill J
    Fed Proc; 1986 Sep; 45(10):2447-2450. PubMed ID: 3743787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.